Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Dimethylfumarate Impairs Neutrophil Functions.
Novel MS Drugs Advance
Influence of infection on exacerbations of multiple sclerosis.
Live Webcast: Assessing the Potential Impact of New and Emerging Disease-Modifying Therapies on the Initial Treatment and Comprehensive Management of Multiple Sclerosis
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
Relapse Rates in Patients with Multiple Sclerosis Switching from Interferon to Fingolimod or Glatiramer Acetate: A US Claims Database Study.
Episode 29 with Dr. Monica Carson on MS research funding
Dimethyl fumarate for multiple sclerosis.
Benefit of interferon beta-1a on MSFC progression in secondary progressive MS.
Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?
Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.
Immune Tolerance and Autoimmune Disease Conference
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
Episode 2 with Dr. Barbara Koppel on recommendations for cannabis in MS
Discovery of CNS Penetrant CXCR2 Antagonists for the Potential Treatment of CNS Demyelinating Disorders.
Understanding the Metabolic Consequences of Human Arylsulfatase A Deficiency through a Computational Systems Biology Study.
Neuroimmunology: Phase II trial demonstrates efficacy of erythropoietin in optic neuritis.
Therapy Optimization in Multiple Sclerosis: A cohort study of therapy adherence and risk of relapse.
Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation.
Association between beta-interferon exposure and hospital events in multiple sclerosis.
Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997-2008.
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
Tizanidine: Can Buy Uk
White Matter Diffusion Changes during the First Year of Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.

Pages